Sexual knowledge · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
Participant satisfaction · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
Effect on later sexual function · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Sexual distress (sexual distress) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Vasomotor symptoms (vasomotor) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Measures of psychosocial factors · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Physical symptoms (physical) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Sexual symptoms (sexual) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Body image · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Quality of life · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Intervention not reported
Intervention: radiotherapy Comparison: no adjuvant treatment Outcome: neurocognitive impairment at 5‐ to 6‐year · people with glioma surviving at least two years
It is very uncertain whether the intervention changes intervention: radiotherapy Comparison: no adjuvant treatment… (very low certainty).
1 finding from 1 review
Intervention not reported
Intervention: radiotherapy Comparison: no adjuvant treatment Outcome: neurocognitive impairment at 12 year · people with glioma surviving at least two years
It is very uncertain whether the intervention changes intervention: radiotherapy Comparison: no adjuvant treatment… (very low certainty).
1 finding from 1 review
Intervention not reported
Intervention: radiotherapy Comparison: no adjuvant treatment Outcome: neurocognitive impairment at 2 year · people with glioma surviving at least two years
It is very uncertain whether the intervention changes intervention: radiotherapy Comparison: no adjuvant treatment… (very low certainty).
1 finding from 1 review
Intervention not reported
Intervention: radiotherapy Comparison: chemotherapy Outcome: neurocognitive impairment at 3 year · people with glioma surviving at least two years
The intervention showed no clear difference in intervention: radiotherapy Comparison: chemotherapy Outcome:… (low certainty).
1 finding from 1 review
Intervention not reported
Intervention: high‐dose radiotherapy Comparison: low‐dose radiotherapy Outcome: neurocognitive impairment at 2 years after treatment · people with glioma surviving at least two years
It is very uncertain whether the intervention changes intervention: high‐dose radiotherapy Comparison: low‐dose… (very low certainty).
1 finding from 1 review
Intervention not reported
Intervention: high‐dose radiotherapy Comparison: low‐dose radiotherapy Outcome: neurocognitive impairment at 5 years after treatment · people with glioma surviving at least two years
It is very uncertain whether the intervention changes intervention: high‐dose radiotherapy Comparison: low‐dose… (very low certainty).
1 finding from 1 review
Intervention not reported
Intervention: chemoradiotherapy Comparison: radiotherapy Outcome: neurocognitive impairment at 3 years after treatment · people with glioma surviving at least two years
The intervention showed no clear difference in intervention: chemoradiotherapy Comparison: radiotherapy Outcome:… (low certainty).
1 finding from 1 review
Intervention not reported
Intervention: stereotactic conformal radiotherapy Comparison: radiotherapy Outcome: neurocognitive impairment at 5 years after treatment · people with glioma surviving at least two years
The intervention showed no clear difference in intervention: stereotactic conformal radiotherapy Comparison:… (low certainty).
1 finding from 1 review
Intervention not reported
Overall survival (deaths at 1 year) · adults with glioblastoma
It is very uncertain whether the intervention changes overall survival (deaths at 1 year) (very low certainty).
1 finding from 1 review
Intervention not reported
Overall survival (deaths at 2 years) · adults with glioblastoma
It is very uncertain whether the intervention changes overall survival (deaths at 2 years) (very low certainty).
1 finding from 1 review